Skip to main content
Commentary
Real-world evidence and nonrandomized data in health technology assessment: using existing methods to address unmeasured confounding?
- Cormac J Sammon,
- Thomas P Leahy,
- Sandro Gsteiger, and
- Sreeram Ramagopalan
pp969–972
Published Online:6 August 2020
Meta-Analysis
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy
- Craig Campbell,
- Richard J Barohn,
- Enrico Bertini,
- Brigitte Chabrol,
- Giacomo Pietro Comi,
- Basil T Darras,
- Richard S Finkel,
- Kevin M Flanigan,
- Nathalie Goemans,
- Susan T Iannaccone,
- Kristi J Jones,
- Janbernd Kirschner,
- Jean K Mah,
- Katherine D Mathews,
- Craig M McDonald,
- Eugenio Mercuri,
- Yoram Nevo,
- Yann Péréon,
- J Ben Renfroe,
- Monique M Ryan,
- Jacinda B Sampson,
- Ulrike Schara,
- Thomas Sejersen,
- Kathryn Selby,
- Már Tulinius,
- Juan J Vílchez,
- Thomas Voit,
- Lee-Jen Wei,
- Brenda L Wong,
- Gary Elfring,
- Marcio Souza,
- Joseph McIntosh,
- Panayiota Trifillis,
- Stuart W Peltz,
- Francesco Muntoni,
- on behalf of the PTC124-GD-007-DMD Study Group,
- ACT DMD Study Group, and
- the Clinical Evaluator Training Groups
pp973–984
Published Online:27 August 2020
Web-based decision aids to support breast cancer screening decisions: systematic review and meta-analysis
- Lin Yu,
- Ping Li,
- Shu Yang,
- Pingping Guo,
- Xuehui Zhang,
- Na Liu,
- Jie Wang, and
- Wei Zhang
pp985–1002
Published Online:7 October 2020
Research Article
US cost–effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphoma
- Keith A Betts,
- Per-Olof Thuresson,
- Federico Felizzi,
- Ella X Du,
- Ibou Dieye,
- Jia Li,
- Mathias Schulz, and
- Anthony S Masaquel
pp1003–1015
Published Online:8 October 2020
- This article corrects the following:
Corrigendum
- Volume 10Issue 4Journal of Comparative Effectiveness Research
- 8 January 2021
The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany
- Sarah Hofmann,
- Sebastian Himmler,
- Dennis Ostwald,
- Ulrich Dünzinger,
- Aino Launonen, and
- Per-Olof Thuresson
pp1017–1026
Published Online:5 October 2020
Cost-minimization analysis of negative pressure wound therapy technologies for the treatment of moderate-to-severe foot infections
- Peter J Mallow,
- Jon Tepsick,
- Kathryn E Davis, and
- Lawrence A Lavery
pp1027–1033
Published Online:9 October 2020